Cardlytics (NASDAQ:CDLX) reported Q4 2023 earnings of $0.14 per share, beating the analyst estimate by 16.67%. Sales of $89.167 million missed the estimate by 0.43%. The company saw a 148.28% increase in earnings compared to the same period last year.
Cardlytics (NASDAQ:CDLX) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.12 by 16.67 percent. This is a 148.28 percent increase over losses of $(0.29) per share from the same period last year. The company reported quarterly sales of $89.167 million which missed the analyst consensus estimate of $89.551 million by 0.43 percent. This is a 8.08 percent increase over sales of $82.503 million the same period last year.
